JFG
BMY icon

JDM Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

JDM Financial Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30
Closed -$1.83K – 267
2025
Q1 		$1.83K Hold
30
– – ﹤0.01% 247
2024
Q4 		$1.7K Hold
30
– – ﹤0.01% 262
2024
Q3 		$1.55K Buy
+30
New +$1.41K ﹤0.01% 268

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JDM Financial Group's BMY Position: Q2 2025 in Review

JDM Financial Group sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 30 shares — an estimated $1.83K sold.

JDM Financial Group first reported a position in BMY in Q3 2024 and held it in 3 quarters. The position peaked at $1.83K in Q1 2025. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • JDM Financial Group reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • JDM Financial Group sold 30 Bristol-Myers Squibb shares in Q2 2025, an estimated $1.83K.
  • JDM Financial Group first reported a position in Bristol-Myers Squibb in Q3 2024 and held it in 3 quarters.
  • JDM Financial Group's Bristol-Myers Squibb position peaked at $1.83K in Q1 2025.
  • 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on JDM Financial Group's 13F filing for Q2 2025, filed 4 Aug 2025.